Health behaviors and quality of life of cancer survivors in Massachusetts, 2006: data use for comprehensive cancer control.

INTRODUCTION: Nearly 12 million cancer survivors are living in the United States. Few state-based studies have examined the health status and health-related quality of life (HRQOL) of this growing population. The objective of this study was to use Massachusetts Behavioral Risk Factor Surveillance System (BRFSS) data to describe cancer survivors' demographics, health behaviors, quality of life, use of preventive care services, and influenza vaccination rates. METHODS: The demographic characteristics of cancer survivors and respondents without cancer were estimated on the basis of responses to questions in the 2006 Massachusetts BRFSS. We used multivariate logistic regression to compare health behaviors, comorbidities, quality of life, and cancer screening and influenza vaccination rates for cancer survivors compared with respondents who did not have cancer. RESULTS: Cancer survivors and respondents who did not have cancer had similar rates of health behavioral risk factors including smoking, obesity, and physical activity. Rates of chronic disease (eg, heart disease, asthma) and disability were higher among cancer survivors. Cancer survivors reported higher rates of influenza vaccination and breast, colorectal, and cervical cancer screening than did respondents who did not have cancer. Survivors' self-reported health status and HRQOL (physical and mental health) improved as length of survivorship increased. CONCLUSION: This state-based survey allowed Massachusetts to assess health-related issues for resident cancer survivors. These findings will help state-based public health planners develop interventions to address the long-term physical and psychosocial consequences of cancer diagnosis and treatment.

The influence of black race on treatment and mortality for early-stage breast cancer.

BACKGROUND: Black Americans have higher mortality from breast cancer than white Americans. This study explores the influence of socioeconomic factors and black race on treatment and mortality for early-stage breast cancer. METHODS: A cohort of 21,848 female black and white, non-Hispanic subjects from the Massachusetts Cancer Registry diagnosed with stage I or II breast cancer between 1999-2004 was studied. Subjects with tumors larger than 5 cm were excluded. We used mixed modeling methods to assess the impact of race on guideline concordant care (GCC), defined as receipt of mastectomy or breast conserving surgery plus radiation. Cox proportional hazard regression was used to assess disease-specific mortality. RESULTS: Blacks were less likely to receive GCC after adjusting for age and clinical variables (OR: 0.75; 95% CI: 0.61, 0.92). Marital status and insurance were predictors of receipt of GCC. After adjustment for all covariates, there were no longer significant differences between black and white women regarding the receipt of GCC. Nevertheless, black women were more likely to die of early-stage breast cancer than white women after adjusting for clinical, treatment, socioeconomic variables, and reporting hospital (HR: 1.6; 95% CI: 1.1-2.1). CONCLUSIONS: Socioeconomic factors are mediators of racial differences in treatment outcomes. Significant racial differences exist in disease-specific mortality for women with early-stage breast cancer. Attention to reducing socioeconomic barriers to care may influence racial differences in breast cancer treatment and mortality.

Prevalence, stability, and socio-demographic correlates of depressive symptoms in Black mothers during the first 18 months postpartum.

OBJECTIVES: The goals of this longitudinal study were to evaluate 1) the prevalence and stability of high depressive symptom levels during the first 18 months postpartum in a sample of otherwise healthy Black mothers varying in socio-economic status and 2) the relation of sociodemographic variables and level of socio-demographic risk to maternal depressive symptom levels during this time period. METHODS: Participants were 163 Black adult mothers of healthy, full-term infants. The level of mothers' depressive symptomatology was assessed at 2, 3, 6, 12, and 18 months postpartum using the Center for Epidemiological Studies-Depression Scale (CES-D). Mothers provided socio-demographic information at each assessment. Univariate and bivariate analyses were used to analyze the data. RESULTS: The percentage of mothers with an elevated CES-D score (16 or higher) at single visits ranged from 13.5 to 14.7%, and 35.0% had at least one elevated CES-D score by 18 months postpartum. CES-D total scores were significantly correlated across each pair of visits (mean r = 0.57, all p's < 0.0001), and average CES-D scores did not change significantly over time. Single marital status, low-income status, and more negative maternal perceptions of the adequacy of income for meeting familial needs were significantly related to higher maternal CES-D scores at each assessment (all p's < 0.05). Level of socio-demographic risk, as assessed with a composite risk score derived from these variables, was significantly related to higher average CES-D scores (averaged across visits) (p < 0.0001) and to a greater frequency of elevated CES-D scores (16 or higher) during the first 18 months postpartum (p = 0.0002). CONCLUSIONS: The prevalence and stability of high levels of maternal depressive symptomatology during the first 18 months postpartum in this sample of Black women are consistent with those reported in prior studies of community samples of mothers unselected for race. Mothers with higher socio-demographic risk profiles had higher levels of maternal depressive symptoms at each assessment point.